Life Sciences Training Course Calendar

Back to details

Training format

Topic

Our Life Sciences calendar for the next 12 months:

Live online Classroom 2025
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Risk Management for Clinical Research Clinical Research 6 7
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Regulatory Affairs 1 4
A Practical Approach to Veterinary Vaccine Development and Registration in the EU Regulatory Affairs 13-14 6-7
A Practical Guide to Producing and Maintaining the PSMF Vigilance 14 23 3
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 21 11 12
A Practical Introduction to Good Clinical Practice (GCP) GxP 24-25 7-8
A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU and UK Regulatory Affairs 30 21
AI in Pharmacovigilance Vigilance 12 7 19
Additional Risk Minimization Measures (aRMMs) and Their Effectiveness Vigilance 9 10 3
Advanced Pharmacovigilance Vigilance 24-26 2-4 6-10
Advanced Project Management in Clinical Research Clinical Research 9 3
Advanced Regulatory Affairs for Medical Devices Regulatory Affairs 3-4 2-3
Advanced Veterinary Pharmacovigilance Vigilance 24-25 15-16
An Essential Overview of Medical Information Regulatory Affairs 14 18 4
An Essential Overview of Pharmacovigilance Vigilance 15 8-9
An Essential Overview of the Medical Device Industry Regulatory Affairs 14 3 7
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 12 22
An Introduction to Ethylene Oxide (EO) Sterilization for Medical Devices GxP 1 10
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 17 9 20
An Introduction to ISO 11607 - Packaging for Terminally Sterilized Medical Devices GxP 22 17
An Introduction to ISO 13485: 2016 - Quality Management System (QMS) for Medical Devices GxP 13 3 19
An Introduction to Pharmaceutical Packaging GxP 2-4 24-26
An Introduction to Pharmacology in Drug Development Clinical Research 18 8 18
An Introduction to Upstream and Downstream Manufacturing in the Biopharmaceutical Industry GxP 4 12 5
An Introduction to the Design and Development of Medical Devices Medical Technology 8-9 23-24 10-11
An Introduction to the Medical Device Regulation Regulatory Affairs 16-18 3-5
An Introduction to the ‘Soft Side’ of Technology Transfers GxP 16 3
An introduction to Risk Management ISO 14971:2019 Regulatory Affairs 11 11 11
Animal Feed and Feed Additive Registration in China and Thailand Regulatory Affairs 27 26 23
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Regulatory Affairs 9 17 10
Application of Artificial Intelligence (AI) and Machine Learning in Clinical Trial Data Management Clinical Research 10 30 6
Be In the Know With Pharma 4.0: Building The Business Case For Pharma 4.0 Medical Technology 12 16
Be In the Know With Pharma 4.0: Digital CMC Medical Technology 19 23
Be In the Know With Pharma 4.0: Digital Technology Transfer Medical Technology 5 9
Best Practice for Writing Effective SOPs Regulatory Affairs 27 17 4
Best Practices for Supplier Qualification in Life Science GxP 27-28 16-17 13-14
Biological Evaluation of Medical Devices Regulatory Affairs 15-16 15-16
Biosimilars Biopharma 21-22 30-1
Biotechnology for the Non-Biotechnologist Biopharma 24-28 9-11 10-14
Building Better Health via Digitalised and Personalised Patient Support Programmes Clinical Research 12 2 5
CAPA (Corrective and Preventative Action) Regulatory Affairs 28 18 5
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 27-28 26-27 20-21
Classification of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs 28 9 12
Cleaning Validation - Best Practice in Pharmaceuticals GxP 8-9 8-9 2-3
Clinical Evaluation of Medical Device Software and Software as a Medical Device Clinical Research 22 13 1
Clinical Evaluation of Medical Devices: The Clinical Evaluation Report Clinical Research 21-22 25-26
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 5-6 18-19 1-2
Clinical Quality Management Systems Clinical Research 22-23 18-19
Clinical Research Project Management Clinical Research 11-13 22-24
Clinical Trial Monitoring Clinical Research 28-29 21-22 8-9
Clinical Trial Regulatory Requirements Clinical Research 20-21 8-9 15-16
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Clinical Research 19 17
Cosmetovigilance Vigilance 19-20 13-14
Cyber Security for Medical Devices Regulatory Affairs 8-9 11-12
Data Innovation for AI-enabled Medical Devices Regulatory Affairs 28 9 12
Data Integrity Auditor Masterclass GxP 4-5 12-13 15-16
Data Integrity and Document Management GxP 7 14 11
Deep Dive into the IVDR Annex XIII Regulatory Affairs 5 10 5
Developing and Managing Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs 3 10 13
Development of Combination Products: Critical Interactions GxP 24-25 2-3
EU Clinical Trial Regulation 536/2014: Overview and Implementation Experience Clinical Research 13-14 2-3 13-14
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 10-11 9-10 6-7
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 20 19 16
Effective Technical Writing & Editing Medical Writing 5 1
Effective Technology Transfer GxP 3-4 2-3 6-7
European Post Marketing Pharmacovigilance - Including the EMA/PRAC Deliberations and Brexit Implications Vigilance 3-7 14-16 3-7
FDA Approval Process for Medical Devices Regulatory Affairs 31-1 22-23 2-3
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 14 1 21
GMP Principles in Vaccine Manufacturing GxP 16-17 10-11 10-11
Global Market Access for Medical Device Software Regulatory Affairs 31-1 8-9 1-2
Good Distribution Practices of Pharmaceuticals and APIs GxP 17-18 9-10 17-18
Human Factors and Usability Engineering in the Development of Drug Delivery Products Regulatory Affairs 13-14 16-17
ICH Q9(R1) Quality Risk Management (QRM) GxP 12 9
Innovate: The MedTech Series – Digital Health Medical Technology 27 7
Innovate: The MedTech Series – The EU AI Act Regulatory Affairs 3 2
Introduction to Veterinary Pharmacovigilance Vigilance 10-11 3-4 5-6
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Regulatory Affairs 5-6 16-17 4-5
Introduction to the New Performance Evaluation Requirements Mandated Under the IVDR (2017/746) Regulatory Affairs 4 9 4
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Clinical Research 6-7 23-24 16-17
Market Authorisation of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs 26-27 7-8 10-11
Masterclass: Market Authorisation of AI-enabled Medical Devices Regulatory Affairs 4 11 14
Medical Device Regulation in the Eurasian Union, Russia and the CIS Regulatory Affairs 3-4 23-24 9-10
Medical Device Regulations in the Middle East and North Africa Regulatory Affairs 10-11 23-24 19-20
Medical Device Single Audit Programme (MDSAP) GxP 24-25 10-11 26-27
Medical Device Studies: Clinical Evidence Clinical Research 7-8 15-16
Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Clinical Research 7-8 15-16
Medical Editing for Peer-Reviewed Journals Medical Writing 8 8
Medical Writing for Consumers Medical Writing 1 1
Medical Writing for Medical Devices Medical Writing 1-2 20-21
Medical Writing with Artificial Intelligence (AI) Medical Writing 29 15
Metered Dose Inhaler (MDI) Technology Medical Technology 24-27 19-20 8-9
Metrics and Earned Value in Clinical Research Projects Clinical Research 5 22 24
Microbiomics in Clinical Trials Clinical Research 27 4 14
Molecular Biology for the Non-molecular Biologist Pharmaceutical 25-26 3-4 9-10
Navigating China’s API Regulations: An Essential Guide to DMF Registration GxP 12 23 23
Navigating Regulatory Compliance Whilst Developing and Distributing PCR-Based IVD Tests Regulatory Affairs 6 26 6
New EU GMP Annex 1: Compliant Aseptic Operations GxP 11-13 1-3 25-27
Non-Conformance and Corrective Action for Medical Device Manufacturers Regulatory Affairs 10 18 11
Pharmaceutical Development of ATMPs GxP 17-18 13-14
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 24-25 8-9 4-5
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 25-27 11-13 8-10
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 8-9 25-26 26-27
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 6-7 19-20 2-3
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 25-26 23-24 21-22
Pharmacovigilance Aspects of Licensing Agreements Vigilance 10 1 1-2
Pharmacovigilance QMS & Inspection Preparation Vigilance 20-21 19-20 25-26
Post-Market Surveillance - Practical Application for Medical Devices and IVDs Regulatory Affairs 12 5 9
Post-market Surveillance and Vigilance of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Vigilance 2-3 10-11 3-4
Practical Implementation of GCP in Veterinary Field Studies GxP 14-15 25-26
Practical Implementation of a Human Factors Study Regulatory Affairs 4-5 1-2 18-19
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 12-13 16-17
Pre-Filled Syringes: End-to-End Processing Medical Technology 20-21 21-22 5-6
Process Validation for Medical Devices GxP 25-26 5-6 22-23
Process Validation with Qualification GxP 20-21 22-23
Protein Engineering for Pharmaceutical Biotechnology Pharmaceutical 8-9 10-11
Real World Evidence (RWE), Real World Data (RWD) and the Application of Artificial Intelligence (AI) in The Pharmaceutical Market Clinical Research 26 16 19
Registration of Veterinary Pharmaceuticals in China Regulatory Affairs 27 26 23
Regulatory Affairs for Support Staff Regulatory Affairs 27-28 12-13 22-23
Regulatory Strategies for Orphan Drugs Regulatory Affairs 23 7
Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP) Vigilance 21 24
Signal Detection and Regulatory Expectations Vigilance 17-18 7-8 18-21
Smart Packaging and Electronic Patient Information GxP 13 3 3-4
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 24-27 21-22 10-11
Sterilization of Medical Devices GxP 3-4 5-6 16-17
Successful Medical Writing – from Protocol to CTD Medical Writing 5-6 25-26
Sustainable Design and Manufacture for Medical Devices Medical Technology 24 3 27
The Advancement of Research and Development (R&D) Clinical Trials using Software Automation Clinical Research 4 1
The Animal Health Summer School: Working Through Veterinary Drug Development in the EU and USA Regulatory Affairs 16-19
The Common Technical Document GxP 11-12 7-8 24-25
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 13 1 28
The FDA Drug Approval Process Regulatory Affairs 24-25 11-12 7-8
The Importance of Patient Adherence Data and How Digital Tools Can Improve Patient Outcomes Clinical Research 26 18 15
The Medical Device Summer School - From Concept to CE Marking Regulatory Affairs 9-13
The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Regulatory Affairs 12-13 13-14
The Role of the Person Responsible for Regulatory Compliance (PRRC) Under the MDR and IVDR Regulatory Affairs 23 22 22
Thinking Outside of the GMP Box GxP 13-14 17-18
UK Conformity Assessed (UKCA) Marking for Medical Devices Regulatory Affairs 26 21
US FDA - Understanding Key Factors When Working with the FDA Biopharma 13 11 26
Understanding Active Pharmaceutical Ingredients (APIs) GxP 25-26 16-17 19-20
Understanding Computer System Validation (CSV) GxP 18-19 9-10 24-25
Understanding Pharmacovigilance Regulations in APAC Vigilance 13-14 16-17 9-10
Unique Device Identification (UDI) and Labelling for Medical Device Manufacturers Regulatory Affairs 24 8 20
Variations to Marketing Authorisations Regulatory Affairs 3-4 15-16
Veterinary Pharmaceutical Submissions in the EU Regulatory Affairs 19-20 25-26